Marcio Jose Sanchez / AP
"Due out this fall, ... this is the 10th anniversary of the original iPhone," Bloomberg's Mark Gurman writes. "[T]he new iPhone won't be a case-study of innovation, more a matter of perfecting features that are already out there in rival devices. Time and again, Apple has followed this 'best, not first' philosophy."
Illustration: Aïda Amer/Axios
FBI Headquarters. Photo: Mark Wilson/Getty Images
Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.
Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.
A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images
Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.
Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.